1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
Djos, Anna ; Svensson, Johanna ; Gaarder, Jennie ; Umapathy, Ganesh ; Nilsson, Staffan ; Ek, Torben ; Vogt, Hartmut ; Georgantzi, Kleopatra ; Öra, Ingrid LU
and Träger, Catarina
, et al.
(2024)
In Genes Chromosomes and Cancer
63(7).
p.1-10
- Contribution to journal › Article
- 2022
-
Mark
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
- Contribution to journal › Article
-
Mark
Amplification of CDK4 and MDM2 : a detailed study of a high-risk neuroblastoma subgroup
Martinez-Monleon, Angela ; Kryh Öberg, Hanna ; Gaarder, Jennie ; Berbegall, Ana P ; Javanmardi, Niloufar ; Djos, Anna ; Ussowicz, Marek ; Taschner-Mandl, Sabine ; Ambros, Inge M and Øra, Ingrid LU
, et al.
(2022)
In Scientific Reports
12.
p.1-17
- Contribution to journal › Article
- 2020
-
Mark
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
- Contribution to journal › Article
- 2014
-
Mark
Emergence of New ALK Mutations at Relapse of Neuroblastoma.
- Contribution to journal › Article